Know what’s in your vial.

Labelled contents: 10mg
Listed purity: 99.76%

A Certificate of Analysis is not currently linked for this product.

Published research

Published research is separate from the batch test results for this vial.

BPC-157: preclinical tendon research

NEWFor research use only

BPC-157 10mgResearch Peptide

Name: BPC-157 10mg
Brand: PepC.Labs
SKU: bpc-157
Price: 85.00 AUD
Availability: InStock

Synthetic 15-amino-acid peptide corresponding to a partial sequence of body protection compound. Studied in preclinical tendon, ligament and gastrointestinal mucosal research models.

PRODUCT DOCUMENTATIONASK SUPPORT

Listed Purity

99.76%

Method

HPLC

Certificate

Not published

$85AUDinc. GST

$8.50 / mg

In stock, ships from Sydney

You'll need this to reconstitute

Bacteriostatic water · 10ml · $20

This peptide ships lyophilised and must be mixed with bacteriostatic water before use.

COA not currently published

For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.

Synthetic 15-amino-acid peptide corresponding to a partial sequence of body protection compound. Studied in preclinical tendon, ligament and gastrointestinal mucosal research models.

Listed purity

99.76%

Amount per vial

10mg

Form

Lyophilized

Overview

BPC-157 is a synthetic pentadecapeptide, a chain of 15 amino acids corresponding to a partial sequence of body protection compound, a protein first described in gastric juice. It has been investigated in published preclinical research, mostly in rodent and cell culture models.

This vial contains 10mg of BPC-157 as a lyophilised powder for reconstitution with sterile diluent in the laboratory.

What is BPC-157?

BPC stands for "body protection compound". BPC-157 is a stable 15-amino-acid fragment of that sequence and has been studied in laboratory settings since the early 1990s.

Published research in animal models has explored BPC-157 in the context of:

Tendon and ligament injury models

Gastrointestinal mucosal lesion models

Angiogenesis and vascular research

Nitric oxide signalling studies

Fibroblast outgrowth and migration in cell culture

Mechanism Research

Preclinical and in vitro studies have examined BPC-157 in relation to VEGFR2-Akt-eNOS signalling, the nitric oxide system and growth hormone receptor expression in tendon fibroblasts. These mechanisms remain an active area of investigation and have not been established in humans.

Published Research

Published research on BPC-157 has been conducted primarily in rodent models and cell culture. Areas of investigation have included:

Achilles tendon and medial collateral ligament transection models in rats

Induced gastric and intestinal lesion models

Vascular and angiogenesis endpoints

Fibroblast outgrowth and migration in vitro

Clinical data in humans is very limited, and BPC-157 is not approved by the TGA for any therapeutic indication.

Quality and Verification

Where a laboratory report is published for this product, it is linked on this page. Check its sample description, methods and batch information, and contact support to confirm documentation for the batch you need. The vial is shipped lyophilised to preserve stability during transit and should be stored at -20°C prior to reconstitution and 2-8°C after reconstitution in the laboratory.

Disclaimer

For research use only. Not for human consumption. The information provided is for educational and research purposes only. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult published peer-reviewed literature before designing research protocols.